Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epigenetic Regulation of Stress-related Genes in MDMA-Assisted Psychotherapy for PTSD
NCT06189027Phase 3Completed
- Sponsor
- University of Southern California
- Start
- Nov 2018
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of midomafetamine in post-traumatic stress disorder (PTSD), sponsored by University of Southern California. Started Nov 2018; status: completed.
02
Drugs
midomafetamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT06189027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06189027.